Share
COVID-19: DRC to return AstraZeneca vaccines to UNICEF
The Democratic Republic of Congo has revealed that it will return a total of 1.3 million doses out of the 1.7 million AstraZeneca vaccines it received to the United Nations Children's Fund, for redistribution to other African countries. Dr. Holenn Serge Emmanuel, Managing Director and co-owner of Medecins De Nuit Sarl, a private clinic and COVID-19 Vaccination Center joins CNBC Africa for more.
Fri, 30 Apr 2021 13:24:34 GMT
Disclaimer: The following content is generated automatically by a GPT AI and may not be accurate. To verify the details, please watch the video
AI Generated Summary
- Issues surrounding AstraZeneca's safety and efficacy led to delays in vaccination rollout in DRC.
- Efforts to accelerate vaccination have been hindered by challenges in utilizing allocated vaccine doses efficiently.
- The decision to return excess vaccines aims to prevent wastage and facilitate effective vaccine distribution across African countries.
The Democratic Republic of Congo has made a significant decision to return 1.3 million out of the 1.7 million doses of AstraZeneca vaccines it received to the United Nations Children's Fund for redistribution to other African countries. Dr. Saaj Holen Emmanuel, the managing director and co-owner of Medisad, Dan Wissar, a private clinic and a COVID-19 vaccination center in DRC, shed light on the reasons behind this move and provided a valuable update on the COVID-19 situation in the country. In an exclusive interview with CNBC Africa, Dr. Emmanuel discussed the challenges and considerations that led to the decision to return the vaccines, as well as the current state of the pandemic in DRC. The Republic of Congo has faced hurdles in its vaccination program due to concerns over AstraZeneca's safety and efficacy, prompting the Ministry of Health to delay the vaccination rollout. Despite efforts to ramp up vaccination efforts, the country has struggled to utilize the allocated doses efficiently, leading to the decision to return excess vaccines for redistribution. This strategic move aims to prevent wastage and ensure that the vaccines are utilized effectively to combat the ongoing pandemic. Dr. Emmanuel emphasized the importance of maximizing the impact of vaccine distribution in the region and highlighted the collaborative efforts of organizations like COVAX in supporting vaccination initiatives in African countries. As DRC navigates the challenges posed by the pandemic, the decision to return AstraZeneca vaccines signifies a proactive approach to optimizing vaccine utilization and enhancing regional vaccination efforts.
SIGN UP FOR OUR NEWSLETTER
DAILY UPDATE
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.